1.
Chinese Journal of Radiation Oncology
;
(6)1993.
Article
in Chinese
| WPRIM
| ID: wpr-679110
ABSTRACT
0.05), especially the survival rate of stage ⅢA disease.Conclusions Concurrent chemoradiotherapy seems to be better than the sequential counter part for NSCLC,without 3 increasing the toxicity.